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Using a candidate-gene approach, we detected a variant of SCN5A, encoding
the cardiac Naþ channel Nav1.5, by screening a family with cardiac arrhythmia
resulting in frequent premature ventricular contractions (PVCs) and non-
sustained ventricular tachycardia. Arrhythmia mechanism involved ectopic
foci originating from the His-Purkinje system. The same mutation, leading to
the R222Q substitution, was present in two additional unrelated families with
the same associated cardiac phenotype. Exercise or hydroquinidine dramati-
cally decreased the number of PVCs. To evaluate the functional incidence of
this substitution, whole-cell patch-clamp experiments were performed on trans-
fected COS-7 cells. The activation and inactivation curves were negatively
shifted in the presence of the mutation (V1/2act, WT:30.652.1 mV, n=9; het-
erozygous: 37.251.6 mV, n=9; p<0.05; V1/2inact, WT: 79.650.7 mV,
n=10; heterozygous: 82.251 mV, n=9; p<0.05) whereas the current density
was unchanged. The use of depolarizing-voltage ramp confirmed the increase
and negative shift of the TTX-sensitive window current (potential of gmax,
WT: 42.850.5 mV, n=12; homozygous: 58.651.1 mV, n=, p<0.001).
WT and R222Q peak INa were similarly half-reduced by 30 mM quinidine
(p<0.001 vs control) as well as the window current (WT: from 1.8750.42
to 0.7450.16 pA/pF in quinidine, n=7; homozygous: 2.5450.41 to
1.1750.12 pA/pF in quinidine, n=6; p<0.001 vs. control).
We carried out computer simulations in single-cell models of human Purkinje
fibers and ventricle action potentials (AP). In heterozygous conditions, incom-
plete repolarization occurred in Purkinje cells only.We also built a multicellular
model incorporating both cell models. In the heterozygous conditions, incom-
plete repolarization in the Purkinje fibers triggered premature APs propagating
into the ventricle. This was normalized at higher pacing frequency or when
quinidine was ‘added’.
From all these studies, the premature ventricular contractions are explained by
the appearance of electrical abnormalities rather in Purkinje fibers than in ven-
tricular cardiomyocytes.
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Heterozygous loss-of-function mutations in the SCN5A gene encoding the car-
diac Naþ channel Nav1.5 cause various hereditary arrhythmias including Bru-
gada syndrome (BrS), a disease characterized by ST-segment elevation in the
ECG right precordial leads, and an increased risk of sudden cardiac death.
Here, we aimed to study the role of the Nav1.5 evolutionarily conserved N-ter-
minus of which the function remains unknown. We characterized two muta-
tions within the cytoplasmic N-terminus of Nav1.5, R104W and R121W
identified in BrS patients and a construct where this region was deleted. In
HEK cells, R104W, R121W and Nav1.5-DNter abolished INa. Immunostaining
of Nav1.5 transfected in neonatal rat cardiomyocytes showed retention of
R104W and R121W in cytoplasmic compartments, as opposed to the WT chan-
nels. Moreover, Western blot analysis revealed that mutants were mostly de-
graded and that the ubiquitin proteasome inhibitor, MG132, prevented this
degradation. Coexpression of WTwith either mutants, mimicking the heterozy-
gous state of BrS patients, led to a marked INa density reduction (80%) and a 8
mV positive shift of the V0.5 activation, compared to WT alone, demonstrating
a dominant-negative effect. Interestingly, when Nav1.5-DNter was coexpressed
with WT, no dominant-negative effect was observed. We demonstrated that (i)
the two N-terminal mutation abolish INa through retention of the mutant chan-
nels and their subsequent degradation by the proteasome, (ii) the two mutant
channels exert a specific dominant-negative effect on WT channels by produc-
ing a default in WT channel trafficking to the membrane, (iii) these mutations
have more drastic effects on INa than deletion of this region. Altogether, our re-
sults suggest that the N-terminal domain of Nav1.5 plays an important role in
the traffic of Nav1.5 subunits to the plasma membrane, the regulation of their
expression and their activation.2685-Pos Board B455
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Background: Intracellular NADH downregulates cardiac Naþ current (INa)
acutely to a magnitude seen in Brugada Syndrome by activating protein kinase
C (PKC). The decrease in INa can be ameliorated by protein kinase A (PKA)
activators. PKC and PKA down- and upregulates INa, respectively. Here, we
studied the roles of known channel phosphorylation sites.
Methods: HEK293 cells transfected with human cardiac Naþ channel wild
type (WT), S1503A, S1503D, S525/528A, and RRR533-535AAA, were uti-
lized for whole-cell patch clamp recording. Peak INa was measured at 30
mV with holding potential at 100 mV. All data were compared with WT.
Results: The peak INa of all mutants was similar to that of the WT channel.
Compared to the WT Nav1.5, the peak INa obtained with application of 100
mMNADH decreased to 4155% (P<0.01). Application of NADH failed to re-
duce INa of S1503A (8156%) but not of S1503D (4252%, P<0.01). PMA,
a PKC activator, decreased INa of WT and S1503D (4755% and 3756%, re-
spectively, P<0.01), but not that of S1503A (87511%, P>0.05). The NADH-
induced decrease in INa could be ameliorated with the PKA activator, forskolin
in S525/528A (92510%) but not RRR533-535AAA (4755%, P<0.01). The
latter mutation also prevented NADþmediated current recovery. Conclusions:
The relatively retained current with the 1503 mutations alone and the lack of
effect on INa by PKC activation of 1503A but not 1503D suggests that phos-
phorylation at this site is necessary but not sufficient to explain the NADH-
dependent reduction in INa. The PKA-dependent rescue of current seems to
be dependent on phosphorylation of the channel at the RRR533-535 sites.
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The tetrodotoxin (TTX)-resistant voltage gated sodium channels, NaV1.8 and
NaV1.9, are important for neuronal pain pathways. NaV1.9 (a.k.a. NaN) is pref-
erentially expressed in nociceptive neurons of dorsal root ganglia. The role of
NaV1.9 in inflammatory and neuropathic pain along with a restricted cellular lo-
calization makes it an attractive target for novel analgesics. Most of our knowl-
edge about NaV1.9 function comes from studies of rodent sensory neurons using
internal solutions and recording protocols to differentiate NaV1.8 and NaV1.9
currents, as well as recent studies using neurons isolated from NaV1.8-null
mice. To further elucidate the functional properties of NaV1.9, we developed
a stable cell line expressing full length humanNaV1.9. ND7/23 cells were stably
transfected using a novel transposon system in combination with human b1 and
b2 sodium channel accessory subunits. Whole-cell currents were recorded from
a holding potential of120mV and elicited with 20ms pulses from80 toþ50
mV in the continuous presence of 200 nM TTX to block an endogenous TTX-
sensitive sodium current. We recorded slow-activating, persistent sodium cur-
rents in NaV1.9 expressing cells following 24 h incubation at 28
C (to boost
cell surface expression). The whole-cell current peaked at 30 mV (15.2 5
1.8 pA/pF, n=26) and exhibited a voltage-dependence of activation with V½
of 50.55 1 mV and slope factor (k) of 7.25 0.3 (n=26). Activation kinetics
was much slower than that observed for neuronal, TTX-sensitive NaV channels;
time to peak current (at30 mV) was 12.65 0.7 ms, n=26. Preliminary single
channel recording demonstrated frequent late re-openings and a single channel
conductance of ~16 pS. These results demonstrate the biophysical properties of
stably expressed human NaV1.9 channel and provide a cell based platform for
the analysis of potential NaV1.9 therapeutic agents.
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Introduction: Infarcts are responsible for cardiac arrhythmias and transient is-
chemic episodes. It has been demonstrated that the neuronal sodium channels
(nNavs) are overexpressed around an ischemic area. Ischemias induce a depolar-
ization of the membrane potential and it’s known that nNavs channels activate
at more depolarized potentials than the cardiac sodium channels (Nav1.5). We
hypothesised that this overexpression of nNavs channels may act as a safety
factor for cardiac conduction during ischemia. However, the nNavs have
a larger late component than Nav1.5 therefore prolonging the action potential
duration (APD) and creating an arrythmogenic substrate (AS). The aim of this
